In addition to metastatic breast tumors expressing wild-type ER [Figure 1A], alterations in ESR1 itself, such as ESR1 amplifications have been identified in metastatic ER+ disease[22] [Figure 1B] . Here, ESR1 is linked to breast neoplasm.